Mitigating The Risk Of Pitfalls In Nasal Drug Product Development, Testing, And Manufacturing
Intranasal drug delivery offers a promising route for administering medications, but the journey from molecule to market can be fraught with peril. Especially in the critical areas of chemistry, manufacturing, and controls (CMC), unidentified risks can significantly impact your program's success.
Join us in this webinar as our experts discuss common pitfalls encountered during the development, testing, and manufacturing of intranasal drug products. We'll explore the potential causes and consequences of these issues, and provide practical recommendations to avoid them or mitigate their effects.
By understanding and addressing these CMC risks proactively, you can ensure your intranasal drug reaches patients safely and effectively, while safeguarding the integrity of your entire development program.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.